About the ATLAS project -Cancer Research Network in Asia by NCC Japan-
Our project, officially named “Asian Clinical Trials Network for Cancers Project: ATLAS project”, was launched in September 2020 with the funding and support from the Japanese government and Japan Agency for Medical Research and Development (AMED). Our missions are to support education and training, to install infrastructures for conducting clinical trials, and to conduct multiple international collaborative studies in parallel.
In addition, we have established the National Cancer Center Asian Partnerships Office for the purpose of responding immediately to the problems that would occur at each local site and obtaining the primary information through face-to-face communication with local liaison officers and reflect while conducting the project.
As a future deployment, we continue to encourage participation of stakeholders such as pharmaceutical companies, CROs, and patient groups worldwide and aim to build a system in which we can conduct more than five international collaborative studies in parallel in Asian region by utilizing the platform of the ATLAS project.
ATLAS project mission
In September 2020, the National Cancer Center launched the Asian Clinical Trials Network for Cancers Project (ATLAS project) with support from the government and AMED.
Leader’s Vision
The main three ATLAS supporters will discuss their aspirations and the reasons behind their enthusiasm about the project
From the Director
The National Cancer Center Hospital has launched ATLAS (Asian clinical TriaLs network for cAncerS) project with the aim of establishing a clinical research network across Asia. This ATLAS project is funded by Japan Agency for Medical Research and Development (AMED) .
About Asian Partnerships Office
The Asian Partnerships Office was established in Bangkok, Thailand on September 10, 2021. The purpose of the Office in Thailand is to provide local support to neighboring participating ASEAN countries for the ATLAS project.
ATLAS Monthly Webinar
This is a seminar series focused on sharing the latest topics in cancer research, targeting physicians, researchers, and clinical trial professionals. Through this webinar, we provide participants with the opportunity to learn about the most recent developments in cancer treatment. The series covers a wide range of topics, from basic research to clinical applications.
ATLAS Board
The ATLAS project aims to establish an international clinical trial group, leveraging a network of Asian countries. Established on March 16, 2023, the ATLAS Board consists of representatives from numerous Asian countries and the project's direction, strategy, and activities. Meeting quarterly, the Board ensures the long-term development of ATLAS through diverse and comprehensive discussions. Members are chosen from institutes involved in ATLAS clinical research and patient enrollment.
Participating Institutions
Introducing the participating institutions of the ATLAS project.
Institutions Development
In the ATLAS project, we will establish a clinical trial network through the development of institutions in order to enable clinical trials to be conducted at overseas sites.
History
In September 2020, the National Cancer Center Hospital launched the ATLAS (Asian clinical TriaLs network for cAncerS) project, to establish a clinical research network across Asia supported by the Japan Agency for Medical Research and Development (AMED).
Organization chart
The organization chart summarizes the relationship between the ATLAS project at the National Cancer Center Hospital and each clinical department.
ATLAS Activity Report
This is a page for ATLAS project activity reports, please visit this page as well as social networking sites.
